Literature DB >> 8437861

c-Ets-1 protein is hyperphosphorylated during mitosis.

L F Fleischman1, A M Pilaro, K Murakami, A Kondoh, R J Fisher, T S Papas.   

Abstract

The ets-1 and ets-2 proto-oncogene products can serve as transcription factors and become phosphorylated in response to Ca(2+)-mediated signals. We have examined expression of Ets proteins during the cell cycle in cells synchronized by centrifugal elutriation or nocodazole-induced mitotic block. Both methods revealed the presence of a hyperphosphorylated isoform of Ets-1 during the mitotic phase. This isoform showed a characteristic mobility shift and was observed during mitosis in each of four cell lines (three human T-cell lines and a human astrocytoma) that express ets-1. In elutriated cells, only a small portion of the Ets-1 in cells from the G2/M fractions was hyperphosphorylated, while in nocodazole-arrested cells more of the Ets-1 was shifted. When cells were released from nocodazole arrest, this isoform disappeared within 1-2 h as cells completed mitosis and entered G1. This suggests that hyperphosphorylated Ets-1 is present transiently during early mitosis, before or around the time of the metaphase-anaphase transition. Exposure of unsynchronized cells to okadaic acid resulted in a dramatic hyperphosphorylation of virtually all Ets-1, suggesting that changes in cellular phosphatase activity are important for cell cycle regulation of Ets-1. Hyperphosphorylated Ets-1 appears to arise from multiple phosphorylations on serine in the exon 7-encoded domain of the protein and did not appear to alter sequence-specific DNA-binding activity. Although enhanced phosphorylation of Ets-2 was detected in nocodazole-arrested cells, no Ets-2 hyperphosphorylation was seen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437861

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.

Authors:  T L Goetz; T L Gu; N A Speck; B J Graves
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Characterization of the cooperative function of inhibitory sequences in Ets-1.

Authors:  M D Jonsen; J M Petersen; Q P Xu; B J Graves
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  ets-1 in astrocytes: expression and transmitter-evoked phosphorylation.

Authors:  L F Fleischman; L Holtzclaw; J T Russell; G Mavrothalassitis; R J Fisher
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

4.  Real-time DNA binding measurements of the ETS1 recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms.

Authors:  R J Fisher; M Fivash; J Casas-Finet; J W Erickson; A Kondoh; S V Bladen; C Fisher; D K Watson; T Papas
Journal:  Protein Sci       Date:  1994-02       Impact factor: 6.725

Review 5.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

6.  ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.

Authors:  D N Sgouras; M A Athanasiou; G J Beal; R J Fisher; D G Blair; G J Mavrothalassitis
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.